Storyline · technology · 2 reports from 2 newsrooms

DEA bans SR-17018, a potential opioid withdrawal aid

First reported Nov 3, 5:00 AM ET · Latest Nov 4, 10:08 AM ET · Explainer updated Nov 4, 12:01 PM ET

Where things stand

The U.S. Drug Enforcement Administration placed SR-17018 in Schedule I, effectively banning the drug, according to reports from Ars Technica and WIRED.

Continuum

The living record of this story: every fact with its status and source, updated as reporting comes in. Version 1, updated . Earlier versions

Facts

What the reporting says

Each fact is matched to the exact words of the report it comes from, and checked that those words really say it. Open one to see the source.

  • Reported The DEA banned a drug that some opioid users called a miracle. Is this wrong?
    Source
    • “The DEA banned a drug some opioid users called a miracle.” — Ars Technica
  • Reported Researchers say the Schedule I ban could kill studies of a promising opioid treatment. Is this wrong?
    Source
    • “Researchers say the Schedule I ban could kill studies of a promising opioid treatment.” — Ars Technica
  • Reported Opioid users say SR-17018 can remove withdrawal symptoms. Is this wrong?
    Source
    • “people addicted to opioids say SR-17018 can remove withdrawal symptoms.” — WIRED
  • Reported The DEA placed SR-17018 in the same category as heroin. Is this wrong?
    Source
    • “the DEA has placed it in the same category as heroin.” — WIRED

How to read the labels: Reported: one newsroom · Corroborated: two or more independent newsrooms · Confirmed: backed by a primary source such as an official release or filing · Disputed: newsrooms disagree · Updated: replaced by a newer figure. This story as data for AI assistants and developers.

Timeline

What changed: The DEA’s new classification makes SR-17018 illegal to possess, distribute, or study.

How this story developed

  1. New The DEA banned a drug that some opioid users called a miracle. Researchers say the Schedule I ban could kill studies of a promising opioid treatment. Opioid users say SR-17018 can remove withdrawal symptoms. The DEA placed SR-17018 in the same category as heroin.

Every report, newest first

  1. The DEA banned a drug some opioid users called a miracle — Ars Technica

    Researchers say the Schedule I ban could kill studies of a promising opioid treatment.

  2. Opioid Users Found a ‘Miracle Drug’ to Help Them Quit. Then the DEA Banned It — WIRED

    On Reddit and Discord, people addicted to opioids say SR-17018 can remove withdrawal symptoms. Despite its potential, the DEA has placed it in the same category as heroin.

Questions

  • It remains unclear whether SR-17018 truly alleviates withdrawal, what its safety profile is, and if any legal challenges or exemptions will be pursued. Open

We send a confirmation first. At most a few emails a day, never overnight, and one click unsubscribes and deletes your address. For readers 13 and over. Privacy

More: background

SR-17018 is a compound that some opioid users say can ease withdrawal symptoms, leading them to label it a “miracle drug.” Schedule I status means the government deems a substance to have high abuse potential and no accepted medical use, which blocks clinical research.

How this works: stories from different newsrooms are grouped by topic, then AI writes the explainer using only those reports. It may miss context the reports don't include.